Savran Technologies is developing non-invasive diagnostics based on capture and analysis of rare cells. Savran Technologies has developed and completed initial testing of a novel liquid biopsy technology. Savran Tech has overcome the challenge of utilizing cell-based liquid biopsy. Cells offer significant advantages over cell-free DNA in diagnostics — for example, they provide access to the entire genome; can provide transcriptional and functional information; can differentiate between primary tumor and metastases; can be cultured for drug screening; and can offer insights into tumor heterogeneity.

We provide shared lab and office space for life science startups. Learn more about our shared lab space in Cambridge and ventures

Contact Us 

(617) 245-8548

325 Vassar St., Suite 2A

Cambridge, MA 02139

Quick Links

Our Services

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram